Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ECF Stock Summary
Top 10 Correlated ETFs
ECF
In the News
BCV And ECF: Convertible Bond Exposure, Offering Yield With Upside Potential
Bancroft Fund and Ellsworth Growth and Income Fund offer diversified exposure to convertible debt investments. Convertible bonds offer yield as fixed-income investments but also potential upside through conversion into common stock. Higher interest rates are leading to higher yields and more issuances of convertibles by higher-rated companies.
ECF: Attractive Discount And Improving Income-Generation
Ellsworth Growth and Income Fund's net investment income has significantly increased, which could provide better coverage of its distribution. ECF continues to trade at an attractive discount, making it a strong investment choice in the convertible space with some equity exposure as well. The fund has also not had to contend with higher interest rates in terms of seeing their borrowing costs rise as they have fixed-rate preferred for their leverage.
CHI: Not A Bargain Yet, Even After Premium Drop
CHI: Not A Bargain Yet, Even After Premium Drop.
Weekly Closed-End Fund Roundup: March 12, 2023
Three out of 22 CEF sectors positive on price and 5 out of 22 sectors positive on NAV last week. Delaware/Abrdn mergers are closed.
Ellsworth Fund: Conservatively Managed Convertibles Fund
ECF is a convertibles-focused CEF. It pays a 5.9% forward distribution yield that appears well covered by historical fund returns.
Kicking Off The New Year With 7 Closed-End Fund Buys In The Month Of January 2023
We have now closed on the first month of the new year, but my strategy of buying every month hasn't changed. The new year has started off with a bang, with the broader indexes jumping higher.
GCV And ECF: A Clear Choice
GCV and ECF are both under the Gabelli umbrella and managed by the same people. GCV's distribution is higher, but ECF's distribution is also a fairly attractive 5% minimum managed policy.
8 Closed-End Funds Bought During January's Rocky Start
8 Closed-End Funds Bought During January's Rocky Start
3 Closed-End Funds Bought In October
October saw the broader indexes return to higher levels after September's dip. I wasn't aggressively buying for the month but found a few pockets worth putting capital to work in.
Gabelli Convertible & Income Securities Fund: An Attractive Higher Yield Convertible Fund
Gabelli Convertible & Income Securities Fund: An Attractive Higher Yield Convertible Fund
ECF Financial details
ECF Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.15 | 2.84 | 3.04 | -4.38 | 0.85 | |
Net income per share | 1.11 | 2.79 | 3 | -4.42 | 0.78 | |
Operating cash flow per share | 1.11 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 1.11 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0.01 | 0 | 0.01 | |
Book value per share | 15.58 | 16.18 | 17.75 | 15.85 | 15.19 | |
Tangible book value per share | 15.6 | 16.21 | 17.77 | 15.85 | 20.39 | |
Share holders equity per share | 15.58 | 16.18 | 17.75 | 15.85 | 15.19 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 120.3M | 145.31M | 170.69M | 91.86M | 65.62M | |
Enterprise value | 120.3M | 145.31M | 170.62M | 91.86M | 65.58M | |
P/E ratio | 9.47 | 4.15 | 4.45 | -1.81 | 10.39 | |
Price to sales ratio | 9.11 | 4.07 | 4.39 | -1.83 | 9.47 | |
POCF ratio | 9.47 | 0 | 0 | 0 | 0 | |
PFCF ratio | 9.47 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.67 | 0.71 | 0.75 | 0.51 | 0.53 | |
PTB ratio | 0.67 | 0.71 | 0.75 | 0.51 | 0.53 | |
EV to sales | 9.11 | 4.07 | 4.39 | -1.83 | 9.47 | |
Enterprise value over EBITDA | 9.47 | 4.15 | 4.45 | -1.81 | 10.38 | |
EV to operating cash flow | 9.47 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 9.47 | 0 | 0 | 0 | 0 | |
Earnings yield | 0.11 | 0.24 | 0.22 | -0.55 | 0.1 | |
Free cash flow yield | 0.11 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | -0.01 | |
Current ratio | 163.83 | 62.3 | 1.82 | 1.85 | 4.24 | |
Interest coverage | 48.84K | 156.43K | 40.56K | -74.29K | 4.63K | |
Income quality | 1 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0.07 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.63 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.01 | -0.01 | 0.07 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 19.7 | 31.85 | 34.63 | 39.72 | 16.27 | |
ROIC | 0.06 | 0 | 0.16 | -0.29 | 0.05 | |
Return on tangible assets | 0.07 | 0.17 | 0.17 | -0.28 | 0.04 | |
Graham Net | 0.23 | 0.08 | 0.07 | -0.01 | 0.05 | |
Working capital | 3.56M | 1.34M | 1.87M | 252.47K | 648.78K | |
Tangible asset value | 178.94M | 203.94M | 227.07M | 181.71M | 166.22M | |
Net current asset value | 3.56M | 1.34M | 1.87M | -2.77K | 648.78K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 2.31M | 2.47M | 2.72M | 2.32M | 677.29K | |
Average payables | 216.88K | 21.88K | 1.15M | 1.29M | 248.63K | |
Average inventory | 0 | 0 | 0.5 | 0.5 | 0 | |
Days sales outstanding | 99.04 | 13.93 | 38.34 | -4 | 42.42 | |
Days payables outstanding | 5.52 | 0 | 459.73 | 63.96 | 45.09 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.69 | 26.19 | 9.52 | -91.32 | 8.61 | |
Payables turnover | 66.12 | 0 | 0.79 | 5.71 | 8.09 | |
Inventory turnover | 3106184.77B | 0 | 1.81M | 0 | 0 | |
ROE | 0.07 | 0.17 | 0.17 | -0.28 | 0.05 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q4
Metric | History | 2022-03-31 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | -0.15 | 0.09 | 0.47 | 0.43 | |
Net income per share | 0 | -2.55 | 0.31 | 0.72 | -0.26 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0.01 | 0.01 | 0 | |
Book value per share | 0 | 13.26 | 13.57 | 9.61 | 9 | |
Tangible book value per share | 0 | 13.26 | 13.57 | 9.61 | 12.09 | |
Share holders equity per share | 0 | 13.26 | 13.57 | 9.61 | 9 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 109.78M | 109.96M | 111.75M | 110.68M | |
Enterprise value | 0 | 109.78M | 109.88M | 111.68M | 110.63M | |
P/E ratio | 0 | -0.79 | 6.39 | 2.82 | -7.68 | |
Price to sales ratio | 0 | -54.04 | 86.52 | 17.44 | 18.68 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0.6 | 0.59 | 0.84 | 0.89 | |
PTB ratio | 0 | 0.6 | 0.59 | 0.84 | 0.89 | |
EV to sales | 0 | -54.04 | 86.46 | 17.43 | 18.67 | |
Enterprise value over EBITDA | 0 | -3.14 | 31.46 | 11.26 | -30.7 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | -0.32 | 0.04 | 0.09 | -0.03 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | -0.02 | -0.01 | 0.01 | |
Current ratio | 1.47 | 1.85 | 1.09 | 1.08 | 4.24 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | -0.22 | 0.35 | 0.07 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 27.58 | 9.76 | 12.48 | 7.29 | |
ROIC | 0 | -0.19 | 0 | 0.07 | -0.03 | |
Return on tangible assets | 0 | -0.19 | 0.02 | 0.05 | -0.02 | |
Graham Net | 0 | -0.01 | -0.02 | -3.98 | 0.03 | |
Working capital | 144.96K | 252.47K | 159.16K | 152K | 648.78K | |
Tangible asset value | 198.34M | 181.71M | 186.97M | 132.45M | 166.22M | |
Net current asset value | -220.65K | -2.77K | 159.16K | -54.37M | 648.78K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 1.22M | 1.89M | 0 | |
Average payables | 0 | 0 | 898.59K | 1.66M | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | -24.35 | 133.84 | 26.55 | 12.23 | |
Days payables outstanding | 0 | 31.97 | 0 | 201.99 | 22.17 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | -3.7 | 0.67 | 3.39 | 7.36 | |
Payables turnover | 0 | 2.82 | 0 | 0.45 | 4.06 | |
Inventory turnover | 0 | 0 | 0 | 3467477.42B | 0 | |
ROE | 0 | -0.19 | 0.02 | 0.07 | -0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ECF Frequently Asked Questions
What is Ellsworth Growth and Income Fund Ltd. stock symbol ?
Ellsworth Growth and Income Fund Ltd. is a US stock , located in Rye of Ny and trading under the symbol ECF
What is Ellsworth Growth and Income Fund Ltd. stock quote today ?
Ellsworth Growth and Income Fund Ltd. stock price is $8.12 today.
Is Ellsworth Growth and Income Fund Ltd. stock public?
Yes, Ellsworth Growth and Income Fund Ltd. is a publicly traded company.